Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

644
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
644
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

361
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
361
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

259
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

p2rx3 Knockout Mice Have Altered Energy Metabolism in Hippocampal Neurons.

Acta naturae·2025
Same author

The P2X3 receptor blocker AF-353 (Ro-4) reduces bioenergetic index of a primary mixed culture of hippocampal neurons.

Biomeditsinskaia khimiia·2025
Same author

Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases.

Doklady. Biochemistry and biophysics·2024
Same author

Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2023
Same author

[APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer's Disease].

Molekuliarnaia biologiia·2023
Same author

Suppression of the Immune Response by Syngeneic Splenocytes Adoptively Transferred to Sublethally Irradiated Mice.

Acta naturae·2021

Related Experiment Video

Updated: Dec 21, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.7K

Animal models of human atherosclerosis: current progress.

A V Poznyak1, Y Y Silaeva2, A N Orekhov1

  • 1Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow, Russia.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|May 20, 2020
PubMed
Summary

Atherosclerosis, a leading cause of death, involves complex factors like lipid metabolism, oxidative stress, and inflammation. Genetically modified animal models are crucial for advancing our understanding and developing new therapies for this disease.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.6K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.8K

Related Experiment Videos

Last Updated: Dec 21, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.7K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.6K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.8K

Area of Science:

  • Cardiovascular Research
  • Translational Medicine
  • Animal Modeling

Background:

  • Atherosclerosis is a primary global cause of morbidity and mortality, particularly in industrialized nations.
  • Current understanding of atherosclerosis pathogenesis is limited due to its multifactorial nature, involving lipid metabolism, oxidative stress, and inflammation.
  • Effective therapeutic interventions require a deeper comprehension of disease mechanisms.

Purpose of the Study:

  • To review recent advancements in creating and utilizing animal models for atherosclerosis research.
  • To discuss key findings derived from these models in understanding disease progression.
  • To highlight the role of genetically modified animals in modeling complex disease aspects.

Main Methods:

  • Review of current literature on animal models for atherosclerosis.
  • Focus on rodent (mice, rats) and rabbit models.
  • Emphasis on genetically modified animal models.

Main Results:

  • Genetically modified animals offer unprecedented capabilities for modeling atherosclerosis.
  • These models facilitate the study of multifactorial disease processes like altered lipid metabolism, oxidative stress, and chronic inflammation.
  • Significant progress has been made in understanding plaque formation and progression using these advanced models.

Conclusions:

  • Animal models, especially genetically modified ones, are indispensable tools for studying atherosclerosis.
  • These models are critical for identifying effective therapeutic targets and developing novel treatments.
  • Continued development and application of animal models will accelerate progress in combating atherosclerosis.